LCG
DPLO

Lisanti Capital Growth’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Lisanti Capital Growth’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-28,837
Closed -$987K – 123
2015
Q4 		$987K Buy
28,837
+13,454
+87% +$420K 1.04% 53
2015
Q3 		$442K Buy
15,383
+7,568
+97% +$324K 0.4% 86
2015
Q2 		$350K Buy
+7,815
New +$294K 0.25% 84

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lisanti Capital Growth's DPLO Position: Q1 2016 in Review

Lisanti Capital Growth sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2016, closing a stake of 28,837 shares — an estimated $987K sold.

Lisanti Capital Growth first reported a position in DPLO in Q2 2015 and held it in 3 quarters. The position peaked at $987K in Q4 2015. 160 funds tracked by Wall St. Rank hold DPLO as of Q1 2016.

  • Lisanti Capital Growth reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2016 after selling out during the quarter.
  • Lisanti Capital Growth sold 28,837 DIPLOMAT PHARMACY, INC. shares in Q1 2016, an estimated $987K.
  • Lisanti Capital Growth first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 3 quarters.
  • Lisanti Capital Growth's DIPLOMAT PHARMACY, INC. position peaked at $987K in Q4 2015.
  • 160 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2016.

Based on Lisanti Capital Growth's 13F filing for Q1 2016, filed 4 May 2016.